Biotechnology company Illumina, Inc. (NASDAQ: ILMN) initiated layoffs within its research and development (R&D) team, affecting approximately 10% of that staff.

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving ...

Illumina, Inc. (NASDAQ:ILMN) Illumina 2024 Strategy Update Special Call August 13, 2024 11:00 AM ETCompany Participants. Salli Schwartz - Head of IR Jacob Thaysen - CEO Steve Barnard - CTO Ankur ...